Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Intelence (etravirine) 100 mg tablets - Important Safety Information from Janssen-Cilag International NV as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
19/10/2009
Problem Or Issue:
Important Safety Information communication from Janssen-Cilag International NV, Toxic epidermal necrolysis (TEN) and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome associated with
Intelence ® (etavirine).
Important Safety Information - Intelence (etravirine) 100 mg tablets - antiviral
« Back
Date Printed: 19/05/2024